Zusammenfassung
Bindegewebetumoren der Haut entstehen aus den Zellen des dermalen, periadnexalen, perivaskulären, subkutanen und faszialen Bindegewebes. Sie sind überwiegend in der Dermis lokalisiert und können das subkutane Fettgewebe involvieren. Die Beteiligung von tiefer gelegenen Strukturen, beispielsweise der Faszie, kommt in Ausnahmefällen vor. Dermal gelegene Tumoren sind prognostisch günstiger als subkutane Pendants.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Caux C, Vanbervliet B, Massacrier C et al. (1996) CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med 184: 695–706
Fletcher CDM (1998) Myofibroblastic tumors: An Update. Verh Dtsch Ges Pathol 82: 75–82
Gabbiani G (1996) The cellular derivation and the life span of the myofibroblast. Path Res Pract 192: 708–711
Mentzel T, Katenkamp D (1998) Myofibroblastäre Tumoren. Pathologe 19: 176–186
Weiss SW, Nickoloff BJ (1993) CD34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 17: 10391045
Cramer HJ, Kahlert G (1968) Über Bindegewebsnaevi. Hautarzt 19: 251–256
Schorr WF, Opitz JM, Reyes CN (1972) The connective tissue nevus-ostiopoikilosis syndrome. Arch Dermatol 106: 208–214
Uitto J, Santa-Cruz DJ, Eisen AZ (1980) Connective tissue nevi of the skin. J Am Acad Dermatol 3: 441–461
Enzinger FM, Weiss S (eds) (1994) Benign fibrous tissue tumors. In: Soft tissue tumors, 3rd edn. Mosby, St. Louis, pp 187–191
Kahn HJ, Hanna WM (1995) „Aberrant elastic“ in elastofibroma: An immunohistological and ultrastructural study. Ultrastruct Pathol 19: 45–50
Ruelas-Villavicencio AL, Aponte-Paredes PS, Ortiz-Hidalgo C (1999) CD34 expression in elastofibroma: Clinicopathological, histochemical, and immunohistochemical study in four cases. Abstract Rev Invest Clin 51: 11–16
Schepel JA, Wille J, Seldenrijk CA, van Ramshorst B (1998) Elastofibroma: A familial occurrence. Eur J Surg 164: 557–558
Nemeth AJ, Penneys NS (1989) Factor XIIIa is expressed by fibroblasts in fibrovascular tumors. J Cutan Pathol 16: 266–271
Pack S, Turner ML, Zhuang Z et al. (1998) Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene. J Invest Dermatol no: 438 440
Roach ES, Gomez MR Northrup H (1998) Tuberous Sclerosis Complex Consensus Conference: Revised clinical diagnostic criteria. J Child Neurol 13: 624–628
Yamamoto T, Katajama I, Nishioka K (1996) Fibropapule multiplex of the nose: A variant of Cowden’s disease? Dermatology 192: 379–381
Cerio R, Rao BK, Spaull J, Wilson Jones E (1989) An immunohistochemical study of fibrous papule of the nose. J Cutan Pathol 16: 194–198
Tope WD, Sangueza OP (1994) Rhinophymas fibrous variant. Histopathology and immunohistochemistry. Am J Dermatop atho l 16: 307–310
Ferenczy A, Richart RM, Wrigt TC (1991) Pearly penile papules: Absence of human papilloma virus DNA by polymerase chain reaction. Obstet Gynecol 78: 118–122
O’Neil CA, Hansen RC (1995) Pearly penile papules on the shaft–letter. Arch Dermatol 131: 491–492
Perrin C, Baran R (1994) Invaginated fibrokeratoma with matrix differentiation: A new histological variant of acquired fibrokeratoma. Br J Dermatol 130: 654–657
Spitalny AD, Lavery LA (1992) Acquired fibrokeratoma of the heel. J Foot Surg 31: 509–511
Cribier B, Gambini C, RaineroM, Grosshans E (1995) Multi-nucleate cell angiohistiocytoma. A review and report of four cases. Acta Dermatol Venereol 75: 337–339
Smolle J, Auboeck L, Gogg-Retzer I, Soyer HP, Kerl H (1989) Multinucleate cell angiohistiocytoma: A clinicopathological, immunohistochemical and ultrastructural study. Br J Dermatol 121: 113–121
Banik R, Lubach D (1987) Skin tags: Localization and frequencies according to sex and age. Dermatologica 174: 180–183
Eads TJ, Chuang TY, Fabre VC, Farmer ER, Hood AF (1996) The utility of submitting fibroepithelial polyps for histological examination. Arch Dermatol 132: 1459–1462
Morgan MB, Howard HG, Everett MA (1997) Epithelial induction in dermatofibroma: A role for the epidermal growth factor ( EGF) receptor. Am J Dermatopathol 19: 35–40
Nestle FO, Nickoloff VI, Burg G (1995) Dermatofibroma: An abortive immunoreactive process mediated by dermal dendritic cells? Dermatology 190: 265–268
Glusac EJ, Barr RJ, Everett MA, Pitha J, Santa Cruz DJ (1994)
Epithelioid cell histiocytoma. Am J Surg Pathol 18: 583–590 Junkins-Hopkins JM, Johnson WC (1998) Desmoplastic
fibroblastoma. J Cutan Pathol 25: 450–454
Zelger BG, Zelger B (1998) Dermatofibrome. Ein klinisch-pathologisches Klassifikationsschema. Pathologe 19: 412–419
Zelger BW, Steiner H, Kutzner H (1996) Clear cell dermatofibroma. Am J Surg Pathol 20: 483–491
Zelger BG, Zelger B (1998) Dermatofibrome. Ein klinisch-pathologisches Klassifikationsschema. Pathologe 19: 412–419
Calonje E, Fletcher CDM (1993) New entities in soft tissue tumors. Pathologica 85: 1–15
Calonje E, Mentzel T, Fletcher CDM (1994) Cellular benign fibrous histiocytoma. Am J Surg Pathol 18: 668–676
Sass U, André J, Noel CH et al. (1994) Tumeur plexiforme fibrohistiocytaire. Ann Dermatol Venereol 121: 109–112
Fletcher CDM (1998) Myofibroblastic tumors: An Update. Verh Dtsch Ges Pathol 82: 75–82
Kamino H, Reddy VB, Gero M, Greco MA (1992) Dermatomyofibroma. A benign cutaneous, plaque-like proliferation of fibroblasts and myofibroblasts in young adults. J Cutan Pathol 19: 85–93
Kutzner H (1998) Perivaskuläre Myome: ein neues Konzept „myofibroblastärer“ Tumoren mit perivaskulärer myoider Differenzierung. Verh Dtsch Ges Pathol 82: 301–308
Kutzner H, Hügel H, Rütten A, Braun M (1993) Erworbenes gutartiges Myofibrom der Haut ( Adultes Myofibrom ). Hautarzt 44: 561–568
Mentzel T, Katenkamp D (1998) Myofibroblastäre Tumoren. Pathologe 19: 176–186
Mentzel T, Calonje E, Fletcher CDM (1993) Dermatomyofibroma: Additional observations on a distinctive cutaneous myofibroblastic tumor with emphasis on differential diagnosis. Br J Dermatol 129: 69–73
Dal Cin P, Sciot R, De Smet L, van den Berge H (1998) Translocation 2;11 in a fibroma of tendon sheath. Histopathology 32: 433–435
Eckert F, Schauch B (1992) Das Sehnenscheidenfibrom. Ein Fallbericht mit immunhistochemischen Untersuchungen. Hautarzt 43: 92–96
Maluf HM, DeYong BR, Swanson PE, Wick MR (1995) Fibroma and giant cell tumor of the tendon sheath: A comparative histological and immunohistological study. Mod Pathol 8: 155–159
Sciot R, Samson I, van den Berge H, van Damme B, Dal-Cin P (1999) Collagenous fibroma (desmoplastic fibroma): Genetic link with fibroma of tendon sheath? Mod Pathol 12: 565–568
Goldblum JR, Tuthill RJ (1997) CD34 and factor XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma. Am J Dermatopathol 19: 147–153
Kosanke U (1999) Ergebnisse der Therapie des Dermatofibrosarcoma protuberans mit Hilfe der mikrographisch kontrollierten Chirurgie. Medizinische Dissertation, Klinik für Dermatologie/Charité, Humboldt-Universität zu Berlin
Kutzner H (1993) Expression of human progenitor cell antigen CD34 (HPCA-i) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalinfixed, paraffin-embedded tissue. Am J Acad Dermatol 28: 613–617
Zelger B, Sidoroff A, Stanzi U et al. (1994) Deep penetrating dermatofibroma versus dermatofibrosarcoma protuberans. Am J Surg Pathol 18: 677–686
Ding J, Hashimoto H, Sugimoto T, Tsuneyoshi M, Enjoji M (1990) Bednar tumor (pigmented dermatofibrosarcoma protuberans). Acta Pathol Jpn 40: 744–754
Goodland JR, Mentzel T, Fletcher CDM (1995) Low grade fibromyxoid sarcoma: A clinicpathological analysis of eleven new cases in support of a distinct entity. Histopathology 26: 229–237
Orlandi A, Bianchi L, Spagnoli LG (1998) Myxoid dermatofibrosarcoma protuberans: Morphological, ultrastructural and immunohistochemical features. J Cutan Pathol 25: 386–393
Calonje E, Fletcher CDM (1996) Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: Clinicopathologic analysis in 5 cases. J Cutan Pathol 23: 30–36
Sanz-Trelles A, Ayala-Carbonero A, Rodrigo-Fernandez I, Weil-Lara B (1998) Leiomyomatous nodules and bundles of vascular origin in the fibrosarcomatous variant of dermatofibrosarcoma protuberans. J Cutan Pathol 25: 44–49
Fletcher CDM (1998) Recent developments in soft tissue tumors. Verh Dtsch Ges Pathol 82: 33–46
Silverman JS, Tamsen A (1998) A cutaneous case of giant cell angiofibroma occurring with dermatofibrosarcoma protuberans and showing bimodal CD34+ fibroblastic and FXIIIa+ histiocytic immunophenotype. J Cut Pathol 26: 265–270
Mentzel T, Katenkamp D, Fletcher CDM (1996) Low malignancy myxofibrosarcoma versus low malignancy fibromyxoid sarcoma. Distinct entities with similar names but different clinical course. Pathologe 17: 116–121
de Saint-Aubain-Somerhausen N, Rubin BP, Fletcher CD (1999) Myxoid solitary fibrous tumor: A study of seven cases with emphasis on differential diagnosis. Mod Pathol 12: 463–471
Eyden BP, Christensen L, Tagore V, Harris M (1992) Myofibrosarcoma of subcutaneous soft tissue of the cheek. J Submicrosc Cytol 24: 307–313
Mentzel T, Dry S, Katenkamp D, Fletcher CDM (1998) Low-grade myofibroblastic sarcoma. Am J Surg Pathol 22: 1228–1238
Fish FS (1996) Soft tissue sarcomas in dermatology. Dermatol Surg 22: 268–273
Hollowood K, Fletcher CDM (1995) Malignant fibrous histiocytoma: Morphologic pattern or pathologic entity? Semin Diagn Pathol 12: 210–220
Lazova R, Moynes R, May D, Scott G (1997) LN-2 (CD74) a marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma. Cancer 79: 2115–2124
Mentzel T, Calonje E, Wadden C, Camplejohn RS, Beham A, Smith MA, Fletcher CDM (1996) Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 20: 391–405
Ehrlich HP, Desmoulière A, Diegelmann RF et al. (1994) Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 145: 105–113
Lee TY, Chin GS, Kim WJ; Chau D, Gittes GK, Longaker MT (1999) Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 43: 179 - i84
Goodlad JR, Fletcher CDM (1990) Intradermal variant of nodular „fasciitis“. Histopathology 17: 569–571
Kiryu H, Takeshita H, Hori Y (1997) Proliferative Fasciitis. Am J Dermatopathol 19: 396–399
Lai FM-M, Lam WY (1993) Nodular fasciitis of the dermis. J Cutan Pathol 20: 66–69
Price SK, Kahn LB, Saxe N (1993) Dermal and intravascular fasciitis. Am J Dermatopathol 15: 539–543
Samaratunga H, Earle J, O’Loughlin B (1996) Nodular fasciitis and related pseudosarcomatous lesions of soft tissue. Aust N Z J Surg 66: 22–25
Enzinger FM, Weiss S (eds) (1994) Benign soft tissue tumors of uncertain type. In: Soft tissue tumors, 3rd edn. Mosby, St. Louis, pp 1053–1054
Hernandez-Lugo AM, Domínguez-Cherit J, Vega-Memije ME (1999) Digital mucoid cyst: The ganglion type. Int J Dermatol 38: 531–538
Enzinger FM, Weiss S (eds) (1994) Benign soft tissue tumors of uncertain type. In: Soft tissue tumors, 3rd edn. Mosby, St. Louis, pp 1051–1052
Wilk M, Schmoeckel C (1994) Cutaneous focal mucinosis–a histopathological and immunohistochemical analysis of n cases. J Cutan Pathol 21: 446–452
Calonje E, Guerin D, McCormick D, Fletcher CDM (1999) Superficial angiomyxoma: Clinicopathological analysis of a series of distinctive but poorly recognized cutaneous tumors with tendency for recurrence Am J Surg Pathol 23: 910–917
Carney JA, Headington JT, Daniel Su WP (1986) Cutaneous myxomas. Arch Dermatol 122: 790–798
Wilk M, Schmoeckel C, Kaiser HW, Hepple R Kreysel HW (1995) Cutaneous angiomyxoma: A benign neoplasm distinct from cutaneous focal mucinosis. J Am Acad Dermatol 33: 352–355
Cooper PH (1992) Fibrous proliferations of infancy and childhood. J Cutan Pathol 19: 257–67
Gabbiani G, Majno G (1972) Dupuytren’s contracture: Fibroblast contraction? Am J Pathol 66: 131–146
Häyry P, Reitamo JJ, Tötterman S, Hopfner-Hallikainen D, Sivula A (1982) The desmoid tumor. II. Am J Clin Pathol 77: 674–680
Hügel H (1991) Die plaqueförmige dermale Fibromatose. Hautarzt 42: 223–226
Hügel H, Allen PW (1995) Fibromatosen und andere fibroblastisch/myofibroblastisch differenzierte Bindegewebstumoren aus der Sicht des Dermatologen. Z Hautkr 70: 717–724
Jennins TA, Duray PH, Collins FS, Sabetta J, Enzinger FM (1984) Infantile myofibromatosis. Evidence for an autosomal-dominant disorder. Am J Surg Pathol 18: 529–538
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Audring, H., Sterry, W. (2003). Bindegewebetumoren der Haut. In: Kerl, H., Garbe, C., Cerroni, L., Wolff, H.H. (eds) Histopathologie der Haut. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07784-9_34
Download citation
DOI: https://doi.org/10.1007/978-3-662-07784-9_34
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-07785-6
Online ISBN: 978-3-662-07784-9
eBook Packages: Springer Book Archive